Diroximel fumarate NEW
| Price | $53 | $77 | $135 |
| Package | 5mg | 10mg | 25mg |
| Min. Order: | |
| Supply Ability: | 10g |
| Update Time: | 2025-09-29 |
Product Details
| Product Name: Diroximel fumarate | CAS No.: 1577222-14-0 |
| Purity: 99.80% | Supply Ability: 10g |
| Release date: 2025/09/29 |
Product Introduction
Bioactivity
| Name | Diroximel fumarate |
| Description | Diroximel fumarate (Diroximel Fumarete), a prodrug of monomethyl fumarate in a controlled-release formulation, rapidly and potently converts to MMF in the body. |
| Kinase Assay | The kinase reaction system contains BMX or BTK, 1 μL of serially diluted CHMFL-BMX-078, and substrate Poly peptidewith 100 μM ATP. The reaction in each tube is started immediately by adding ATP and kept going for an hour under 37 °C. After the tube cooled for 5 min at room temperature, 5 μL solvent reactions are carried out in a 384-well plate. Then 5 μL of ADP-Glo reagent is added into each well to stop the reaction and consume the remaining ATP within 40 min. At the end, 10 μL of kinase detection reagent is added into the well and incubated for 30 min to produce a luminescence signal. Luminescence signal is measured with an automated plate reader. |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | DMSO : 125 mg/mL (489.77 mM), Sonication is recommended. |
| Keywords | Inhibitor | inhibit | Diroximel Fumarate | Diroximel fumarate | Diroximel | BIIB-098 | BIIB098 | BIIB 098 | ALKS-8700 | ALKS8700 | ALKS 8700 |
| Inhibitors Related | TBHQ | L-Cystine dihydrochloride | Dimethyl fumarate | Methyl 3,4-dihydroxybenzoate | Pyridoxine | Resveratrol | Luteolin | Curcumin | L-Methionine | L-Cystine | 4-hydroxyphenylacetic acid | Lentinan |
| Related Compound Libraries | FDA-Approved & Pharmacopeia Drug Library | Bioactive Compound Library | Anti-Neurodegenerative Disease Compound Library | Approved Drug Library | ReFRAME Related Library | EMA Approved Drug Library | Drug Repurposing Compound Library | NO PAINS Compound Library | FDA-Approved Drug Library | Orally Active Compound Library | Clinical Compound Library | Bioactive Compounds Library Max |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
| $8.00/1KG |
VIP2Y
|
Henan Fengda Chemical Co., Ltd
|
2024-01-22 | |
| $0.00/25Kg/Bag |
VIP5Y
|
Sinoway Industrial co., ltd.
|
2021-08-11 | |
| $0.00/1g |
VIP2Y
|
BEIJING SJAR TECHNOLOGY DEVELOPMENT CO., LTD.
|
2024-09-06 | |
| $1.00/1KG |
VIP5Y
|
Career Henan Chemica Co
|
2020-10-29 |
United States- Since: 2011-01-07
- Address: 36 Washington Street, Wellesley Hill, MA
INQUIRY